Download App

Log in to access Online Inquiry
Company Overview More
Micro Chuangxintong Medical Technology Co., Ltd. is a Chinese investment holding company mainly engaged in the medical device industry. The company is mainly engaged in the R & D and commercialization of transcatheter and surgical solutions in the field of valvular heart disease. The company's main products include the first generation transcatheter aortic valve implantation (TAVI) product "VitaFlow" and the second generation TAVI product "VitaFlow II". The company mainly does business in the domestic market.
CEO: Qiyi Luo
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

02160 CARDIOFLOW-B
2.220+0.080+3.74%
YOY
Do not show
Hide blank lines
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(FY)2019/12/31
Assets
Current assets
Inventory
22.08% 82.73M -- 64.6M 37.67% 67.77M 188.2% 49.22M
Accounts receivable
188.02% 113.48M -- 55.76M 58.12% 39.4M 161.65% 24.92M
Cash and equivalents
261.09% 2.21B -- 2.78B 460.55% 612.47M 116.71% 109.26M
Secured deposit
58985.23% 192.03M -- 325K 0% 325K 0% 325K
Total current assets
261.1% 2.6B -- 2.9B 291.86% 719.97M 137.54% 183.73M
Non-current assets
Property, plant and equipment
292.19% 267.17M -- 92.13M 59.29% 68.12M 25.47% 42.77M
Associated company interest
-- 176.74M -- -- -- -- -- --
Interests in Joint Venture
-2.32% 33.22M -- 33.57M -4.42% 34.01M 1.41% 35.58M
Financial assets at fair value-non-current assets
-57.48% 21.05M -- -- -- 49.51M -- --
Intangible assets
1.96% 238.75M -- 242.43M 5.25% 234.17M 13.28% 222.49M
Other illiquid assets
294.29% 25.27M -- 118.5M -89.55% 6.41M 3.6% 61.33M
Total non-current assets
94.33% 762.19M -- 486.62M 8.29% 392.21M 11.51% 362.17M
Total assets
202.29% 3.36B -- 3.38B 103.73% 1.11B 35.75% 545.9M
Liabilities
Current liabilities
Accounts payable
47.32% 126.78M -- 84.21M 143.58% 86.06M -68.16% 35.33M
Tax payable
-- -- -- 326K -- -- -- --
Bank loans and overdrafts
-- -- -- -- -- -- -- 20M
Derivative financial instrument-current liabilities
-- -- -- -- -- 60.37M -- --
Financial lease liabilities-current liabilities
381.8% 34.7M -- 8.87M -0.65% 7.2M 70.24% 7.25M
Special items of current liabilities
-99.77% 2.96M -- 23K 293.06% 1.28B -- 325.16M
Total current liabilities
-88.51% 164.43M -- 93.43M 269.24% 1.43B 236.55% 387.74M
Net current assets
442.18% 2.44B -- 2.8B -248.86% -711.73M -438.77% -204.01M
Total assets less current liabilities
1100.76% 3.2B -- 3.29B -302.02% -319.51M -44.88% 158.16M
Non-current liabilities
Financial lease liabilities-non-current liabilities
954.33% 90.94M -- 5.19M -24.21% 8.63M -5.63% 11.38M
Deferred income-non-current liabilities
-33.63% 2.25M -- 3.56M -2.59% 3.39M 135.14% 3.48M
Derivative financial instruments-non-current liabilities
-42.16% 7.9M -- 12.97M 19.21% 13.66M -- 11.46M
Total non-current liabilities
293.77% 101.08M -- 21.72M -2.45% 25.67M 94.36% 26.32M
Total liabilities
-81.78% 265.52M -- 115.15M 251.97% 1.46B 221.59% 414.06M
Total assets less total liabilities
997.05% 3.1B -- 3.27B -361.81% -345.18M -51.77% 131.84M
Total equity and non-current liabilities
1100.76% 3.2B -- 3.29B -302.02% -319.51M -44.88% 158.16M
Equity
Share capital
38.33% 83K -- 83K -3.23% 60K -99.54% 62K
Reserve
996.87% 3.1B -- 3.27B -361.98% -345.24M -49.31% 131.78M
Legal reserve
996.87% 3.1B -- 3.27B -361.98% -345.24M -49.31% 131.78M
Shareholders' Equity
997.05% 3.1B -- 3.27B -361.81% -345.18M -51.77% 131.84M
Total equity
997.05% 3.1B -- 3.27B -361.81% -345.18M -51.77% 131.84M
Total equity and total liabilities
202.29% 3.36B -- 3.38B 103.73% 1.11B 35.75% 545.9M
Currency Unit
CNYCNYCNYCNY
Accounting Standards
HKASHKASHKASHKAS
Audit Opinions
Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor
KPMG accounting firm--KPMG accounting firmKPMG accounting firm

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%